CTNM Dividend History & Analysis | Yield
CTNM has a dividend yield of and paid per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| SAN PA Sanofi |
102,720 M | 5.54% | 5.85% |
| BMY NYSE Bristol-Myers Squibb |
118,706 M | 4.71% | 4.59% |
| GSK NYSE GlaxoSmithKline |
107,470 M | 3.72% | 5.48% |
| TAK NYSE Takeda Pharmaceutical |
52,989 M | 3.92% | 4.64% |
| NVS NYSE Novartis |
305,104 M | 3.06% | 6.21% |
| VTRS NASDAQ Viatris |
19,448 M | 3.88% | 4.14% |
| MRK NYSE Merck |
309,642 M | 3.29% | 5.04% |
| NOVN SW Novartis |
294,776 M | 2.99% | 5.55% |
| ORNBV HE Orion |
11,561 M | 2.56% | 5.39% |
| ROP SW Roche Holding |
335,798 M | 3.05% | 3.28% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| HLUN-B CO H Lundbeck |
6,513 M | 26.64% | 100.0% |
| SECT-B ST Sectra (publ) |
5,602 M | 19.74% | 99.2% |
| LLY NYSE Eli Lilly |
1,082,494 M | 15.21% | 100.0% |
| NVS NYSE Novartis |
305,104 M | 8.79% | 100.0% |
| RDY NYSE Dr. Reddy’s Laboratories |
11,974 M | 12.38% | 75.2% |
| MRK NYSE Merck |
309,642 M | 5.41% | 100.0% |
| RPRX NASDAQ Royalty Pharma |
33,266 M | 5.47% | 100.0% |
| SAN PA Sanofi |
102,720 M | 5.39% | 100.0% |
| JNJ NYSE Johnson & Johnson |
633,194 M | 4.89% | 100.0% |
| IPN PA Ipsen |
15,629 M | 7.55% | 98.0% |
CTNM Dividend History
CTNM Dividend FAQ
As of July 2026, CTNM's dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 14.56.
As of July 2026 CTNM does not pay a dividend.
Over the last 12 months, CTNM has issued dividend payments.
Based on historical data, the forecasted dividends per share for CTNM for the next payments are between 0 (+0.0%) and 0 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about -%.
The next Ex-Dividend date for Contineum Therapeutics (CTNM) is currently unknown.
The next Ex-Dividend date for Contineum Therapeutics (CTNM) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
CTNM's average dividend growth rate over the past 5 years is -% per year.
CTNM's 5-Year Yield on Cost is -%. If you bought CTNM's shares at 16.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.
CTNM Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
CTNM's % Dividend Yield is considered as unknown.
The Dividend Payout Ratio of CTNM is unknown.
CTNM's Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
CTNM Outstanding Shares Analysis
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-07-01 03:20 UTC